“Adoption of Safety Pen Needles and Technological Advancements”
- The market is witnessing a shift towards safety pen needles that reduce the risk of needlestick injuries and promote user safety. Manufacturers are focusing on ergonomics and material innovations to make injections less painful and more reliable for chronic conditions such as diabetes.
- For instance, Terumo Corporation introduced a safety pen needle that automatically retracts post-injection, reducing the chances of accidental pricks. Simultaneously, BD and Novo Nordisk have invested in ultra-thin gauge technologies, with BD’s 2025 launch of its 4mm ultra-fine needle gaining traction among insulin-dependent patients for its improved comfort.
